Gsk Share Discussion Threads

[alibizzle] 04/4/2024 13:50

GSK probably go down same route as sanofi .

[tradermichael] 04/4/2024 13:36

SANOFI has reached an agreement in principle to settle 4,000 US lawsuits linking the discontinued heartburn drug Zantac to cancer, the company said on Wednesday (Apr 3). Sanofi did not disclose the financial terms of the deal.

[motorhead75] 03/4/2024 19:31

My musings..
I think the price isn’t going to move a great deal and will bounce around between £16.50-17.20 range up until the Zantac result in June/July.
If we get a positive result, I can see £18.50+ quite quickly- remember the 14% jump after the federal court case result?!
If it’s not in our favour, maybe a £1.50 drop, but regained steadily and will continue to climb.. I do think potential payouts are factored in to the current share price.
It’ll be nice to see this share being given a fair valuation finally- the whole Zantac litigation reaction has baffled me.
I work for GSK and have held shares for thirty years.. hopefully this time next year Rodney, we’ll all be millionaires!

[tradermichael] 03/4/2024 09:35

If the price remains soft I'll be buying in again with the help of GSK's next dividend payment of 16p per share on Apr 11, 2024.

[geckotheglorious] 03/4/2024 08:21

GSK picking up momentum, says HL’s Clayton
GSK (GSK) is ‘fighting back into contention’ with a bumper crop of new product launches in the pipeline, says Hargreaves Lansdown manager Steve Clayton.

Clayton holds the Citywire Elite Companies AAA-rated pharmaceutical giant in his HL Select UK Income Shares fund, where it makes up 3% of the £138m portfolio.

The group has been focused on restructuring, with a spin out of its consumer division Haleon (HLN), and developing new medicines such as shingles vaccine Shingrix, which Clayton said is ‘already a multi-billion dollars a year product’.

The arrival of US activist investors Elliott Management a few years ago highlighted ‘the weak returns GSK had achieved, despite some real clinical strengths within the business’.

‘The company is now more optimistic about its research pipeline delivering more meaningful new drugs than for many years,’ Clayton said.

‘GSK’s business has more clarity about it these days and its current pipeline of 71 assets is predicted by GSK to contain at least 12 major new products to be launched from 2025 onwards.’

The shares dropped 2.5% to £16.65 on Tuesday, but have added almost 16% over the last 12 months.

[tradermichael] 02/4/2024 13:21

It doesn't really matter .... the underlying trend is up - rarely does a share of this magnitude go up in a continuous straight line .... ;o)

[garycook] 02/4/2024 10:08

TM I think you are wrong, GSK were marked down at 8am start of trading by over 2%. With a UT trade of 1653p.There are currently more Buyers than Sellers atm !

[tradermichael] 02/4/2024 09:18

Profit taking ahead of Financial Year end this week?

[garycook] 02/4/2024 08:44

Why, Anybody know ?

[alibizzle] 02/4/2024 08:43

Big drop on share price to start the day

[tradermichael] 30/3/2024 07:38

US news:

Shares of GSK plc (LON:GSK) passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 1,531.56 ($19.35) and traded as high as GBX 1,713 ($21.65).

[igoe104] 21/3/2024 10:02

Momentum traders jumping ship, most probably..

[rikky72] 21/3/2024 09:51

Yes, it has been a little lacklustre the past 6 weeks or so which has been disappointing set against some strong days in the wider market. Persisting Zantac worries, who knows?

[evianone] 21/3/2024 09:33

Support next at £16.20 disappointing with the markets so strong, hope it proves to be or better it doesn't and moves up

[estienne] 21/3/2024 09:29

On past form Blackhorse galloping off is a good omen

[blackhorse23] 21/3/2024 08:50

Money moving to APH [LSE] , excellent profitable healthcare company

[tradermichael] 20/3/2024 14:25

"....keeps falling". You have to take a loooonger term view. For example 8 months ago the price was 1316p (on 7 July 2023)..... ;0)

[rikky72] 20/3/2024 13:14

You should know by now that this share will severely test your patience!

[alibizzle] 20/3/2024 12:00

Yes all this good news and so keeps falling

[tradermichael] 19/3/2024 13:40

UBS confirms its Buy recommendation on the share and raises its target price to 2040 pence (from 1860 pence), representing a potential upside of 23%. ' We are raising our forecasts on Blenrep to reflect the positive results of the DREAMM-7 and DREAMM-8 studies' says the analyst firm.

[tradermichael] 19/3/2024 13:31

Nope, that was just one of many.

[evianone] 19/3/2024 11:37

Its been made by the looks of it
GSK plc (LSE/NYSE: GSK) today (1-2-24) confirmed it has reached a confidential settlement with David Browne, resolving the case he filed in California state court. This case was set to go to trial on 20 February 2024, and instead will now be dismissed.

[alibizzle] 19/3/2024 10:24

When will zantac court case ruling results be made ? I thought that had happened last week when share price dropped 2.5% !

[dplewis1] 19/3/2024 09:41

UBS raises target price to 2040p from 1860p